ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Mr. Michael Farrell 2005 'den beri şirketle birlikte olan Resmed Inc 'in Chairman of the Board 'ıdır.
RSMDF hissesinin fiyat performansı nasıl?
RSMDF 'in mevcut fiyatı $22.61 'dir, son işlem günde 0% azalmış etti.
Resmed Inc için ana iş temaları veya sektörler nelerdir?
Resmed Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Resmed Inc 'in piyasa değerlemesi nedir?
Resmed Inc 'in mevcut piyasa değerlemesi $3.2B 'dir
Resmed Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 19 analist Resmed Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 12 al, 8 tut, 0 sat ve 4 güçlü sat içermektedir